U.S. regulator inspects Indian pharma firms

December 05, 2023 09:43 pm | Updated 09:43 pm IST - Hyderabad

The U.S. Food and Drug Administration (USFDA) is inspecting Dr. Reddy's research and development centre in Hyderabad, the pharma company said on Tuesday.

"We confirm the commencement of a USFDA inspection at our R&D centre," a Reddy's spokesperson said.

A unit of Laurus Labs' subsidiary Laurus Synthesis in Visakhapatnam, Andhra Pradesh is also being inspected by the U.S. drug regulator, according to a source familiar with the matter.

Rivals Sun Pharma's Dadra facility and Torrent Pharmaceuticals Ltd.'s oncology unit are also undergoing FDA inspections, according to media reports.

Sun Pharma, Laurus and Torrent did not immediately reply to Reuters' requests seeking comment.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.